围手术期非血液制品止血药物应用管理专家共识(广东)
Expert consensus on the management of non-blood hemostatic drugs during peri-operative period(Guangdong)
广东省药学会药物警戒专业委员会 郑萍1
作者信息
- 1. 南方医科大学南方医院 广州,510515
- 折叠
摘要
围手术期使用止血药物是减少手术失血,促进患者术后康复的一项重要措施.同时,止血药物使用不当,有可能增加发生血栓栓塞性疾病和血管内弥漫性凝血的风险.为规范围手术期止血药物的合理使用,特制定本共识.该共识基于最新的循证医学证据,并广泛征求了药学和临床专家建议,主要对围手术期常用非血液制品止血药物的作用机制、临床应用建议以及药学监护等方面进行了陈述,旨在为临床医生和外科药师在围手术期合理使用止血药物提供一定的参考.
Abstract
The use of hemostatic drugs during peri-operative period is an important measure to reduce blood loss and promote postoperative rehabilitation.Meanwhile,the improper use of hemostatic drugs may increase the risk of thromboembolic disease and disseminated intravascular coagulation.This consensus is aim to regulate the rational use of hemostatic drugs during peri-operative period.Based on the latest evidence of evidence-based medicine and suggestions from pharmaceutical and clinical experts,this consensus states the mechanism,clinical application suggestions and pharmaceutical care of commonly used non-blood hemostatic drugs during peri-operative period,which doesn't contain blood products.The purpose of this work is to provide reference for clinicians and surgical pharmacists to rationally use hemostatic drugs during peri-operative period.
关键词
围手术期/止血药物/合理用药/药学监护/专家共识Key words
peri-operative period/hemostatic drugs/rational drug use/pharmaceutical monitoring/expert consensus引用本文复制引用
出版年
2024
NETL
NSTL
万方数据